Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: Reclast Effective And Preferred By Patients
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: Birthweight Linked To RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
  See all
osteoarthritis;visfatin/pre-B cell Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: Possible influence on osteoarthritis
Arthritis & Rheumatism, 05/14/08
Print     Email This Article     Save in My Library   Free Abstract
Gosset M et al. – The findings of this study indicate that visfatin, an adipose tissue-derived hormone has a catabolic function in cartilage and may have an important role in the pathophysiology of OA.

Methods
  • A study to investigate the contribution of visfatin to the pathophysiology of OA, by examining its role in PGE2 synthesis and matrix degradation
  • The synthesis of visfatin with and w/o stimulation with IL-1β and the role of visfatin in PGE2 synthesis were analyzed by RT-PCR and immunoblotting
  • The effects of visfatin on mPGES-1 and 15-PGDH synthesis, on the subsequent release of PGE2, and on MMP-3, MMP-13, ADAMTS-4, ADAMTS-5, and PG synthesis were examined by qRT-PCR, immunoblotting, and ELISA
  • siRNA was used to assess the influence of visfatin on IL-1β-induced release of PGE2 in immature mouse articular chondrocytes

Results
  • Human OA chondrocytes produced visfatin, and visfatin synthesis was increased by IL-1β treatment
  • Visfatin, like IL-1β, triggered excessive release of PGE2, due to increased mPGES-1 synthesis and decreased 15-PGDH synthesis
  • Visfatin knockout with siRNA reduced IL-1β-induced PGE2 overrelease
  • Visfatin triggered ADAMTS-4 and ADAMTS-5 expression and MMP-3 and MMP-13 synthesis and release
  • It reduced synthesis of high molecular weight PG by immature mouse articular chondrocytes

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- OSTEOARTHRITIS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.